glutathione for parkinson's disease IV Therapy Glutathione for Parkinson's Disease -

Based on advancements in folate metabolism research, in 1980, scientists described the 'folate trap', a phenomenon in which the enzyme methionine synthase (MTR), in the absence of its cofactor (vitamin B12), is unable to convert homocysteine into methionine

PMC 4575440

(125) used 16S rRNA gene sequencing to examine the composition of the intestinal flora in 154 patients with type 2 diabetes mellitus, 73 of whom had normal cognitive function and 81 of whom had impaired cognitive function

A precise, validated half-life in humans has not been published in peer-reviewed literature

BPC157 is emerging as a powerful therapy for Crohns disease